Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP962309.RALhoyl06aivk21Axx61FiYiqEsG5M5BkmC6EaIGDMT0A130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP962309.RALhoyl06aivk21Axx61FiYiqEsG5M5BkmC6EaIGDMT0A130_assertion type Assertion NP962309.RALhoyl06aivk21Axx61FiYiqEsG5M5BkmC6EaIGDMT0A130_head.
- NP962309.RALhoyl06aivk21Axx61FiYiqEsG5M5BkmC6EaIGDMT0A130_assertion wasGeneratedBy ECO_0000203 NP962309.RALhoyl06aivk21Axx61FiYiqEsG5M5BkmC6EaIGDMT0A130_provenance.
- NP962309.RALhoyl06aivk21Axx61FiYiqEsG5M5BkmC6EaIGDMT0A130_assertion wasDerivedFrom befree-2016 NP962309.RALhoyl06aivk21Axx61FiYiqEsG5M5BkmC6EaIGDMT0A130_provenance.
- NP962309.RALhoyl06aivk21Axx61FiYiqEsG5M5BkmC6EaIGDMT0A130_assertion SIO_000772 22351748 NP962309.RALhoyl06aivk21Axx61FiYiqEsG5M5BkmC6EaIGDMT0A130_provenance.
- NP962309.RALhoyl06aivk21Axx61FiYiqEsG5M5BkmC6EaIGDMT0A130_assertion evidence source_evidence_literature NP962309.RALhoyl06aivk21Axx61FiYiqEsG5M5BkmC6EaIGDMT0A130_provenance.
- NP962309.RALhoyl06aivk21Axx61FiYiqEsG5M5BkmC6EaIGDMT0A130_assertion description "[Although the expression of cdr2 onconeural antigen is not high in HER2-positive breast cancers, HER2 overexpression seems to be an important requirement to develop an anti-Yo-associated PCD.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP962309.RALhoyl06aivk21Axx61FiYiqEsG5M5BkmC6EaIGDMT0A130_provenance.